We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The pharmaceutical industry is not doing enough to convey a clear, consistent message to the public, according to the new head of PhRMA, who has vowed to do nothing less than “rescue and restore” the industry’s reputation.
Former HHS Secretary Tommy Thompson has accepted two positions in the private sector — one with law firm Akin Gump Strauss and another with consulting firm Deloitte & Touche, the companies announced March 9.
William Hubbard, the FDA’s long-time associate commissioner for policy and planning, announced his retirement from the agency March 4. Randall Lutter, of the FDA’s Office of Planning, will replace Hubbard.
The medical device industry praised President Bush’s nomination of acting Commissioner Lester Crawford to be the permanent head of the FDA, even as the nominee moved last week to counter criticisms surrounding the embattled agency’s handling of drug-safety issues.
President Bush has nominated Lester Crawford to be commissioner of the FDA — a move that could bring the agency its first permanent leader in nearly a year.